Literature DB >> 11668633

Mutation screening at the RNA level of the STK11/LKB1 gene in Peutz-Jeghers syndrome reveals complex splicing abnormalities and a novel mRNA isoform (STK11 c.597(insertion mark)598insIVS4).

A A Abed1, K Günther, C Kraus, W Hohenberger, W G Ballhausen.   

Abstract

This study was intended to evaluate a diagnostic reverse transcriptase polymerase chain reaction based protein-truncation test for the identification of germline mutations in the serine/threonine protein kinase 11 (STK11, also designated LKB1) gene in Peutz-Jeghers syndrome (PJS). Our data exemplify that the inactivation of STK11 can be due to unusual disturbances in splicing regulation which result in truncations of the protein. However, nonsense mediated mRNA decay must be blocked with puromycin to detect shortened STK11 gene products contained in the leucocytic mRNA pool of PJS patients. Interestingly, two mutations escaped from detection by exon sequencing techniques with usual flanking PCR primers, since alterations were located right in the middle of intronic sequences. We describe a compound heterozygous PJS patient who carried two different mutations in intron 1 on separate alleles. Each of the two mutations was transmitted individually to one of his two children. In the course of our RNA based analyses we detected high level expression of a novel STK11/LKB1 mRNA variant retaining intron 4 (STK11 c.597(insertion mark)598insIVS4) in various tissues. This mRNA isoform was initiated from an alternative transcription regulatory region as revealed by primer extension analyses even in cell lines with complete methylation of the normal promoter. As a consequence of novel mutational mechanisms identified we discuss the impact of RNA based strategies for the detection of germinal STK11 mutations in PJS. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668633     DOI: 10.1002/humu.1211

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome.

Authors:  E Volikos; J Robinson; K Aittomäki; J-P Mecklin; H Järvinen; A M Westerman; F W M de Rooji; T Vogel; G Moeslein; V Launonen; I P M Tomlinson; A R J Silver; L A Aaltonen
Journal:  J Med Genet       Date:  2006-05       Impact factor: 6.318

2.  Exonic STK11 deletions are not a rare cause of Peutz-Jeghers syndrome.

Authors:  N C M Hearle; M F Rudd; W Lim; V Murday; A G Lim; R K Phillips; P W Lee; J O'donohue; P J Morrison; A Norman; S V Hodgson; A Lucassen; R S Houlston
Journal:  J Med Genet       Date:  2006-04       Impact factor: 6.318

3.  Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz-Jeghers syndrome harboring genomic deletion of the STK11 gene.

Authors:  Kenta Masuda; Yusuke Kobayashi; Tokuhiro Kimura; Kiyoko Umene; Kumiko Misu; Hiroyuki Nomura; Akira Hirasawa; Kouji Banno; Kenjiro Kosaki; Daisuke Aoki; Kokichi Sugano
Journal:  Hum Genome Var       Date:  2016-03-03

4.  Deleterious mis-splicing of STK11 caused by a novel single-nucleotide substitution in the 3' polypyrimidine tract of intron five.

Authors:  Thorkild Terkelsen; Ole H Larsen; Søren Vang; Uffe B Jensen; Friedrik Wikman
Journal:  Mol Genet Genomic Med       Date:  2020-06-23       Impact factor: 2.183

5.  Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.

Authors:  J P Koivunen; J Kim; J Lee; A M Rogers; J O Park; X Zhao; K Naoki; I Okamoto; K Nakagawa; B Y Yeap; M Meyerson; K-K Wong; W G Richards; D J Sugarbaker; B E Johnson; P A Jänne
Journal:  Br J Cancer       Date:  2008-07-01       Impact factor: 7.640

6.  Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome.

Authors:  W Lim; N Hearle; B Shah; V Murday; S V Hodgson; A Lucassen; D Eccles; I Talbot; K Neale; A G Lim; J O'Donohue; A Donaldson; R C Macdonald; I D Young; M H Robinson; P W R Lee; B J Stoodley; I Tomlinson; D Alderson; A G Holbrook; S Vyas; E T Swarbrick; A A M Lewis; R K S Phillips; R S Houlston
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

Review 7.  Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function.

Authors:  Ren-You Gan; Hua-Bin Li
Journal:  Int J Mol Sci       Date:  2014-09-19       Impact factor: 5.923

8.  Implications of Splicing Alterations in the Onset and Phenotypic Variability of a Family with Subclinical Manifestation of Peutz-Jeghers Syndrome: Bioinformatic and Molecular Evidence.

Authors:  Andrea Cerasuolo; Francesca Cammarota; Francesca Duraturo; Annamaria Staiano; Massimo Martinelli; Erasmo Miele; Paola Izzo; Marina De Rosa
Journal:  Int J Mol Sci       Date:  2020-11-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.